Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

C001 - Live Demonstration: Soft Tissue Augmentation and Neuromodulators – Simultaneous Cadaver Prosection and Live Patient Injections

Friday, February 16; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize and identify facial and neck anatomy as it relates to the use of cosmetic injections.
  • Assess and avoid complications injecting at various face and neck locations and depths.
  • Develop a therapeutic rejuvenation plan utilizing a combination of nonsurgical treatments.


This session will include demonstration of newly FDA-approved tools to augment existing nonsurgical rejuvenation. Attendees will have the unique opportunity to see live patient assessment and treatments along-side demonstration of pertinent anatomy on a dissected cadaver - techniques have evolved to require injections at various tissue planes, therefore understanding anatomy is extremely important in order to avoid complications and maximize patient outcomes. Live patient demonstrations will include augmentation with dermal fillers, treatment of submental fullness, and optimal use of neuromodulators.


  • Bertucci, Vince, MD: Allergan, Inc – C(Fees); Allergan, Inc. – A(Fees), I(Fees), SP(H); Croma-Pharma GmbH Austria – A(NC); Galderma Canada, Inc – A(Fees), SP(H); Galderma Laboratories, L.P. – A(Fees); Galderma USA – I(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(Fees), SP(Fees); Merz Aesthetics – A(Fees), C(Fees), I(Fees); Revance Therapeutics, Inc. – C(Fees), I(Fees), SP(Fees); TEOXANE Laboratories – A(OB); Valeant Pharmaceuticals International – C(Fees);
  • Butterwick, Kimberly J., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(H); Colorescience – A(H); Evolus, Inc. – A(H); Galderma Laboratories, L.P. – A(H), I(Grants/Research Funding); Histogen Inc. – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – A(H); Revance Therapeutics, Inc. – A(H); Sinclair Pharma, LLC – Speaker/Faculty Education(H);
  • Carruthers, Jean D.A., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Alphaeon – I(Grants/Research Funding); Bonti – C(NC); Kythera – C(H); Kythera Biopharmaceuticals – I(H); Merz Aesthetics – C(H), I(H); Revance Therapeutics, Inc. – I(H);
  • Chilukuri, Suneel, MD: Aclaris Therapeutics Inc. – Speaker/Faculty Education(H); Aerolase – Speaker/Faculty Education(H); Alastin Skincare, Inc – Speaker/Faculty Education(H); Allergan, Inc – Speaker/Faculty Education(H); Alma Lasers – I(NC); BTL Industries – Speaker/Faculty Education(H); Cynosure, Inc – Speaker/Faculty Education(H); Eclipse Medical – Speaker/Faculty Education(EQ); Galderma USA – Speaker/Faculty Education(H); InMode MD Ltd – Speaker/Faculty Education(H); PCA SKIN – Speaker/Faculty Education(H); SkinMedica, Inc. – I(Grants/Research Funding); Suneva Medical, Inc. – Speaker/Faculty Education(H); Theravant Corporation – Speaker/Faculty Education(H);
  • Cotofana, Sebastian, MD, PhD: no financial relationships exist with commercial interests.
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candela Corporation – A(H); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – A(NC); Valeant Pharmaceuticals North America LLC – C(H);
  • Dayan, Steven, MD: Allergan, Inc. – I(Grants/Research Funding); AOBiome, LLC – I(Grants/Research Funding); AstraZeneca – I(Grants/Research Funding); Croma-Pharma GmbH Austria – C(Fees); Eclipse Medical – C(Fees); Galderma Research & Development, LLC – I(Grants/Research Funding); Lumenis – SP(H); Mentor Corporation – I(Grants/Research Funding); Merz Aesthetics – C(Fees); Recros Medica – I(Grants/Research Funding); Revance Therapeutics, Inc. – C(Fees); Stratapharma – C(Grants/Research Funding); Topix Pharmaceuticals, Inc. – I(Grants/Research Funding);
  • Fabi, Sabrina G., MD: Allergan, Inc – I(Grants/Research Funding), Speaker/Faculty Education(H); Bausch Health – C(H), I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Endo International plc – C(H), I(Grants/Research Funding); Galderma Laboratories, LP – SP(H); Merz Aesthetics – I(Grants/Research Funding), Speaker/Faculty Education(H); Revance Therapeutics, Inc. – A(H), C(H), I(Grants/Research Funding); Roche Laboratories – Speaker/Faculty Education(H); SkinCeuticals LLC – SP(H);
  • Hooper, Deirdre, MD: Allergan, Inc – A(H), C(H), SP(H); Almirall – C(H); Asana Biosciences, LLC – I(H); Bellus Medical – A(H); BioPharmX – I(H); Botanix Pharmaceuticals – I(H); Bristol-Myers Squibb – I(H); Clarisonic – C(H); Cutera, Inc. – SP(H); Dermavant Sciences – I(H); Dermira – I(H); Dr Reddy's Laboratory – I(H); DS Biopharma – I(H); Endo International plc – I(H); Evolus, Inc. – A(H); Ferndale Laboratories, Inc. – A(H); Foamix – I(H); Galderma USA – SP(H); Glenmark Generics Inc. – I(H); Incyte Corporation – I(H); Kinex Medical – I(H); La Roche-Posay Laboratorie Pharmaceutique – C(H); Menlo Therapeutics – I(H); Novartis – I(H); PCA SKIN – SP(H); Pfizer Inc. – SP(H); Pixacore – C(H); Qurient, Inc. – I(H); RBC Consultants – C(H); Revance Therapeutics, Inc. – C(H); Sinclair Pharma – A(H); Sol-Gel Technologies – I(H); UCB – I(H); Viviscal – C(H);
  • Humphrey, Shannon, MD: Allergan, Inc – Speaker/Faculty Education(H); Allergan, Inc. – A(H), I(Grants/Research Funding); Evolus, Inc. – I(H); Galderma Laboratories, L.P. – SP(H); Galderma Laboratories, LP – A(H); L'Oréal France – SP(H); Merz Aesthetics – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding), SP(H);
  • Mariwalla, Kavita, MD: Aclaris Therapeutics Inc. – C(Fees); Galderma Argentina, S.A. – SP(Fees); Revance Therapeutics, Inc. – I(Grants/Research Funding); Skinfix, Inc. – C(Fees);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Monheit, Gary D., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Evolus, Inc. – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Suneva Medical, Inc. – C(NC), I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Palm, Melanie, MD: Allergan, Inc – A(H); AmperSand Biopharmaceutical, LLC – I(Fees); BTL Industries – Speaker/Faculty Education(H); Galderma Laboratories, L.P. – C(H); Kythera – Speaker/Faculty Education(H); Lumenis – SP(H); Lutronics, Inc. – C(OB); Merz Aesthetics – Speaker/Faculty Education(H); Valeant Pharmaceuticals International – C(H);
  • Shamban, Ava T., MD: Allergan, Inc – I(Grants/Research Funding), SP(H); Endo International plc – I(Grants/Research Funding); Merz Aesthetics – I(Grants/Research Funding), SP(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Swift, Arthur, MD: Allergan, Inc. – A(H), C(H); Angiotech – I(H); Canderm – SP(H); ColBar LifeScience Ltd. – C(H); Galderma Laboratories, L.P. – C(H); Johnson & Johnson Consumer Products Company – A(H); Medicis Pharmaceutical Corporation – A(H), C(H), I(H); Q-Med – C(H), I(H); sanofi-aventis – SP(H);
  • Weinkle, Allison, MD: no financial relationships exist with commercial interests.
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
  • Zenker, Sabine, MD: L'Oréal France – C(H); Merz Aesthetics – Speaker/Faculty Education(Fees); Sinclair Pharma – A(Fees);
Friday, February 16
9:00 AM
Dr. Weinkle / Introduction
9:05 AM
Dr. Carruthers and Dr. Cotofana / Correlation with Cadaver Anatomy throughout Presentation
9:05 AM
Dr. Monheit and Dr. Weinkle / Upper Face Rejuvenation
9:25 AM
Dr. Palm and Dr. Hooper / Mid-face Rejuvenation
9:45 AM
Dr. Matarasso and Dr. Mariwalla / Lower Face Rejuvenation
10:05 AM
Dr. Bertucci and Dr. Humphrey / Needle Technique
10:25 AM
Dr. Fabi and Dayan / Cannula Technique
10:45 AM
Dr. Shamban and Dr. Chilukuri / Hand Rejuvenation
11:05 AM
Dr. Butterwick and Dr. Zenker / Suture lifting
11:25 AM
Dr. Cox and Swift / Full Face Assessment
11:45 AM
Dr. Weinkle / Q & A
Event Details
  • Date
    Friday, February 16
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 6D
  • CME Credits
  • Type
  • Susan H. Weinkle, MD, FAAD
  • Allison Weinkle, MD
  • Arthur Swift, MD
  • Ava T. Shamban, MD, FAAD
  • Deirdre Hooper, MD, FAAD
  • Gary D. Monheit, MD, FAAD
  • Jean D.A. Carruthers, MD
  • Kavita Mariwalla, MD, FAAD
  • Kimberly J. Butterwick, MD, FAAD
  • Melanie Palm, MD, FAAD
  • Sabine Zenker, MD
  • Sabrina G. Fabi, MD, FAAD
  • Sebastian Cotofana, MD, PhD
  • Seth L. Matarasso, MD, FAAD
  • Shannon Humphrey, MD, FAAD
  • Steven Dayan, MD
  • Sue Ellen Cox, MD, FAAD
  • Suneel Chilukuri, MD, FAAD
  • Vince Bertucci, MD, FAAD